发明名称 |
COMBINATION BREAST CANCER THERAPY WITH HSP90 INHIBITORY COMPOUNDS |
摘要 |
Methods for treating breast cancer, comprising administering to the subject an effective amount of a selective estrogen receptor modulator and an effective amount of a compound represented by the following structural formula: (I) (Ia) a tautomer, or a pharmaceutically acceptable salt thereof. The variables depicted in the structural formula are defined herein. |
申请公布号 |
US2014005145(A1) |
申请公布日期 |
2014.01.02 |
申请号 |
US201113992591 |
申请日期 |
2011.12.07 |
申请人 |
PROIA DAVID;SYNTA PHARMACEUTICALS CORP. |
发明人 |
PROIA DAVID |
分类号 |
A61K31/675;A61K31/138;A61K31/4196;A61K31/565 |
主分类号 |
A61K31/675 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|